8 reports

  • PRODUCT PROFILE - OTHER TRIPTANS
  • 7.1.7 OTHER TRIPTANS
  • Antimigraine
  • Allergan plc
  • Amgen Inc.
  • Eli Lilly & Co.
  • Pfizer Inc.
  • SMALL MOLECULE TO INHIBIT GABA TRANSAMINASE FOR MIGRAINE AND STATUS EPILEPTICUS - DRUG PROFILE
  • ZOLMITRIPTAN - DRUG PROFILE
  • Antimigraine
  • Pain Relief
  • Pharmaceutical
  • United States
  • Product Initiative
  • SMALL MOLECULE TO INHIBIT GABA TRANSAMINASE FOR MIGRAINE AND STATUS EPILEPTICUS - DRUG PROFILE
  • ZOLMITRIPTAN - DRUG PROFILE
  • Antimigraine
  • Pain Relief
  • United States
  • Product Initiative
  • Allergan plc
  • Impact of drivers and challenges
  • Market trends
  • Antimigraine
  • Allergan plc
  • Endo International plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.
  • Clinical Trial profile. 100 Trial Title
  • Official Title

" Triptans are thought to treat migraines by inducing vasoconstriction through other serotonin receptors (##-HT##B/ ##D) on cranial blood vesselshowever, triptans also induce unwanted vasoconstriction of the coronary and carotid arteries.

  • Antimigraine
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Merck & Co., Inc.

triptans Imitrex (GSK), Maxalt (MRK) and Topamax (JNJ), Treximet (PTX), Atacand (AZN) and TI-##.

  • Antimigraine
  • Monoclonal Antibody
  • OTC
  • Pain Relief
  • Therapy
  • Triptan Costs
  • Types of Triptans Currently Available
  • Antimigraine
  • Endo International plc
  • GlaxoSmithKline plc
  • Impax Laboratories, Inc.
  • Pfizer Inc.
  • 6.15.3. DOSAGE FORMS OF RIZATRIPTAN
  • RIZATRIPTAN DOSAGE FORMS

THE DRUG IS A SECOND GENERATION TRIPTAN AND GOT FDA APPROVAL IN JUNE 1998.

  • Antimigraine
  • Europe
  • United States
  • Demand
  • Market Size